Related Experiment Videos
Prognostic factors in surgical resection for hepatocellular carcinoma
1M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Cancer Treatment and Research
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised.
Allergologia et immunopathologia·2014
Uncertain areas in the diagnosis of allergic bronchopulmonary aspergillosis in patients with asthma.
Allergologia et immunopathologia·2013
The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
International clinical psychopharmacology·2012
Clinical features of drug-induced hypersensitivity syndrome in 38 patients.
Journal of investigational allergology & clinical immunology·2011
Use of human amniotic membrane wrap in reducing perineural adhesions in a rabbit model of ulnar nerve neurorrhaphy.
The Journal of hand surgery, European volume·2009
Acute generalized exanthematous pustulosis as a manifestation of carbamazepine hypersensitivity syndrome.
Journal of investigational allergology & clinical immunology·2009
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Brain Network Convergence of Abnormal Gray Matter and Functional Activity of Pathological Dissociative Symptoms.
Psychiatry and clinical neurosciences·2026
SHMT2: a Metabolic and Immune Biomarker of Aggressive Lung Adenocarcinoma.
Journal of visualized experiments : JoVE·2026